Rapid Remission With Upadacitinib in a Child With Refractory Crohn's Disease and ATM Mutation: A Case Report

ABSTRACT: Managing pediatric Crohn's disease (PCD) presents challenges due to severe complications and higher biologic therapy needs. Transitioning from anti–tumor necrosis factor agents to off-label therapies adds complexity. Although upadacitinib has demonstrated efficacy and tolerability in...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Liu, MD, XiaoMei Song, MD, LingYa Xiang, MD, Wei Tan, MD, Min Zou, MD, Hong Guo, MD
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Current Therapeutic Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X24000262
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items